These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6021476)

  • 1. Antibody response to cholera vaccine. Differences between depressed, schizophrenic, and normal subjects.
    Friedman SB; Cohen J; Iker H
    Arch Gen Psychiatry; 1967 Mar; 16(3):312-5. PubMed ID: 6021476
    [No Abstract]   [Full Text] [Related]  

  • 2. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response in the intestinal secretions of volunteers immunized with various cholera vaccines.
    Ganguly R; Clem LW; Bencić Z; Sinha R; Sakazaki R; Waldman RH
    Bull World Health Organ; 1975; 52(3):323-30. PubMed ID: 779998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine specific immune response to an inactivated oral cholera vaccine and EPI vaccines in a high and low arsenic area in Bangladeshi children.
    Saha A; Chowdhury MI; Nazim M; Alam MM; Ahmed T; Hossain MB; Hore SK; Sultana GN; Svennerholm AM; Qadri F
    Vaccine; 2013 Jan; 31(4):647-52. PubMed ID: 23200936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of vibramycin on the immunobiologic activity of the body following immunization with cholera vaccine].
    D'iachenko IA; Piten'ko NN
    Antibiotiki; 1974 Oct; 19(10):909-13. PubMed ID: 4462451
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serologic response in man to cholera vaccine].
    Di Tommaso I
    Ann Sclavo; 1973; 15(4):445-52. PubMed ID: 4788453
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children.
    Suharyono ; Simanjuntak C; Witham N; Punjabi N; Heppner DG; Losonsky G; Totosudirjo H; Rifai AR; Clemens J; Lim YL
    Lancet; 1992 Sep; 340(8821):689-94. PubMed ID: 1355798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward an effective prophylactic immunity to cholera.
    Burrows W
    J Infect Dis; 1970 May; 121():Suppl 121:58+. PubMed ID: 5421430
    [No Abstract]   [Full Text] [Related]  

  • 9. CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation.
    Ahmed T; Arifuzzaman M; Lebens M; Qadri F; Lundgren A
    Vaccine; 2009 Dec; 28(2):422-9. PubMed ID: 19837094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to two cholera vaccines in volunteers.
    Nimbkar YS; Karbhari RS; Cherian S; Chanderkar NG; Bhamaria RP; Ranadive PS; Gaitondé BB
    Prog Drug Res; 1975; 19():544-62. PubMed ID: 1219908
    [No Abstract]   [Full Text] [Related]  

  • 11. [Methods of determination of specific antibodies during cholera and our experiences in their detection in the district of East Slovakia].
    Sónak R; Bohuś J
    Cesk Epidemiol Mikrobiol Imunol; 1972 Sep; 21(5):248-55. PubMed ID: 4263156
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of intradermal and subcutaneous routes of cholera vaccine administration.
    McBean AM; Agle AN; Compaore P; Foster SO; McCormack WM
    Lancet; 1972 Mar; 1(7749):527-9. PubMed ID: 4110029
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study on the immunogenicity and safety of recombinant B-subunit/whole cell cholera vaccine infused with antacids in healthy population at ages of 2-6 years].
    Huang T; Li RC; Liu DP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Sep; 51(9):827-831. PubMed ID: 28881549
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparation and laboratory testing of plain and aluminum hydroxide-adsorbed cholera vaccines used in a field trial in Indonesia.
    Joó I; Csizér Z
    Bull World Health Organ; 1978; 56(4):615-8. PubMed ID: 310362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali.
    Perry RT; Plowe CV; Koumaré B; Bougoudogo F; Kotloff KL; Losonsky GA; Wasserman SS; Levine MM
    Bull World Health Organ; 1998; 76(1):63-71. PubMed ID: 9615498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type-specificity of immunity to antigens of chemical cholera vaccine in mice of different genotypes].
    Pavlova LP; Gor'kova AV; Isupov IV; Dzhaparidze MN; Nazarova LS
    Vestn Akad Med Nauk SSSR; 1983; (9):75-8. PubMed ID: 6637058
    [No Abstract]   [Full Text] [Related]  

  • 17. Genomics of immune response to typhoid and cholera vaccines.
    Majumder PP
    Philos Trans R Soc Lond B Biol Sci; 2015 Jun; 370(1671):. PubMed ID: 25964454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of an oral B subunit whole cell cholera vaccine.
    Svennerholm AM; Jertborn M; Gothefors L; Karim A; Sack DA; Holmgren J
    Dev Biol Stand; 1983; 53():73-9. PubMed ID: 6873479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR.
    Tacket CO; Losonsky G; Nataro JP; Cryz SJ; Edelman R; Kaper JB; Levine MM
    J Infect Dis; 1992 Oct; 166(4):837-41. PubMed ID: 1527420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.